Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Artificial Tears Market from 2024 to 2025?

In recent times, the artificial tears market has been experiencing robust growth. This market is projected to rise from $3.55 billion in 2024 to $3.78 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.5%. Factors contributing to growth during the historical phase include an older population, extended screen usage, expenditure on healthcare, a transition from prescription to over-the-counter (OTC), and regulatory modifications.

What Is the Projected Market Size of the Artificial Tears Market?

Predictions indicate a robust expansion of the artificial tears market in the upcoming years, targeting a valuation of $4.86 billion by 2029, with a compound annual growth rate (CAGR) of 6.5%. The upswing in the projected timeline is primarily due to factors such as the rising cases of dry eye syndrome, increased use of contact lenses, widespread urbanization, escalating pollution levels, and the growth of e-commerce. Key trends expected during this projected period encompass technological progression, incorporation of artificial intelligence, collaborations with healthcare practitioners, usage of natural components, progression in product formulation techniques, advanced drug delivery methodologies and focus on eco-friendly, sustainable products.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13799&type=smp

Who are the Major Competitors in the Artificial Tears Market Outlook?

Major companies operating in the artificial tears market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Abbott Laboratories, Otsuka Pharmaceutical Co. Ltd., Alcon, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr Reddy’s Laboratories, Santen Pharmaceutical Co. Ltd., Lupin Limited, Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., Thea Pharma Inc., OPTIMA pharma GmbH, Sentiss Pharma Pvt. Ltd., VISUfarma B.V., OASIS Medical Inc., Hilco Vision, Similasan Corporation, Eyevance Pharmaceuticals LLC, Nicox S.A., I-MED Pharma Inc., Velocity Pharma LLC

What Is Fueling Growth in the Artificial Tears Market?

The artificial tear market is projected to experience growth due to the ever-increasing presence of dry eye disease. This ailment occurs when eyes don’t create a sufficient volume of tears, or the tears are not of premium quality, causing pain and uneasiness. Artificial tears are used to augment natural tear production, supplying lubrication and easing the discomfort associated with dry eyes. As an example, a study from Macquarie University in Australia revealed in March 2022 that of 5,000 participants aged 50 and older, 13% (15 of 120 people) displayed clinical signs of dry eye disease (DED), with 8.2% mild, 2.5% moderate, and 1.6% in the severe category. Furthermore, in the same month, Eyes On Eyecare, a US digital news source for ophthalmology, communicated that the application of prescribed and in-clinic remedies for dry eye disease escalated from 5.8% in 2021 to 7.56% in 2022. The data showed that the use of prescription treatments such as topical steroids had a striking increase from 0.9% to 9.1% in that time-frame. Due to these reasons, the escalating presence of dry eye disease has spurred the growth of the artificial tear market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13799&type=smp

Which Artificial Tears Market Segments Are Growing the Fastest?

The artificial tears market covered in this report is segmented –

1) By Type: Glycerin Tears, Cellulose Tears, Oil-Based Emulsion Tears, Polyethylene Glycol-based Tears, Sodium Hyaluronate Based Artificial Tears, Propylene Glycol-based Tears

2) By Dosage: Suspensions, Solution, Ointment, Emulsion, Gel, Spray

3) By Indication: Dry Eye Syndrome, Allergies, Infections, UV And Blue Light Protection, Contact Lens Moisture Retention, Other Indications

4) By Distribution: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Ophthalmic Stores

Subsegments:

1) By Glycerin Tears: Preserved Glycerin Tears, Preservative-Free Glycerin Tears

2) By Cellulose Tears: Hydroxypropyl Methylcellulose (HPMC) Tears, Carboxymethylcellulose (CMC) Tears

3) By Oil-Based Emulsion Tears: Mineral Oil-based Tears, Castor Oil-based Tears

4) By Polyethylene Glycol-based Tears: PEG 400 Tears, PEG 3350 Tears

5) By Sodium Hyaluronate Based Artificial Tears: Low Molecular Weight Sodium Hyaluronate Tears, High Molecular Weight Sodium Hyaluronate Tears

6) By Propylene Glycol-based Tears: Preserved Propylene Glycol Tears, Preservative-Free Propylene Glycol Tears

Which Industry Trends Are Shaping the Future of the Artificial Tears Market?

Key players in the artificial tears market are innovating and incorporating technologies such as patented pureflow technology in their products to improve safety and ease of use. Patented pureflow technology is a unique delivery mechanism that uses a unidirectional valve to safeguard the sterile dispensation of preservative-free eye drops, thus averting contamination and preserving the product’s integrity. For example, Alcon Inc., a medical device and pharmaceutical company based in Switzerland, unveiled the Systane Complete Preservative-Free Lubricant Eye Drops in January 2022. These advanced artificial tears are uniquely designed to alleviate symptoms connected to all major kinds of dry eye, including evaporative dry eye and aqueous tear deficiency. Being a preservative-free compound, they offer continuous relief of up to eight hours by hydrating and safeguarding every layer of the tear film. With the use of nano-droplet technology, the drops provide immediate hydration to the eye’s surface, prevent tear evaporation, and provide prompt, efficient relief. Enclosed in a handy multi-dose bottle featuring the PureFlow technology, the design safeguards by averting contamination, proving it to be an excellent choice for regular users and those having prone eyes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-tears-global-market-report

Which Countries Are Leading the Artificial Tears Market?

North America was the largest region in the artificial tears market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial tears market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13799

This Report Delivers Insight On:

1. How big is the artificial tears market, and how is it changing globally?

2. Who are the major companies in the artificial tears market, and how are they performing?

3. What are the key opportunities and risks in the artificial tears market right now?

4. Which products or customer segments are growing the most in the artificial tears market?

5. What factors are helping or slowing down the growth of the artificial tears market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model